Silexion Therapeutics LTD (SLXN)
NASDAQ: SLXN
· Real-Time Price · USD
0.81
-0.03 (-3.78%)
At close: Jun 17, 2025, 3:58 PM
0.84
3.21%
After-hours: Jun 17, 2025, 07:56 PM EDT
-3.78% (1D)
| Bid | 0.8 |
| Market Cap | 7.05M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -13.34M |
| EPS (ttm) | -1.93 |
| PE Ratio (ttm) | -0.42 |
| Forward PE | -0.8 |
| Analyst | Buy |
| Ask | 0.85 |
| Volume | 256,347 |
| Avg. Volume (20D) | 1,639,657 |
| Open | 0.83 |
| Previous Close | 0.84 |
| Day's Range | 0.80 - 0.86 |
| 52-Week Range | 0.21 - 13.56 |
| Beta | 0.12 |
About SLXN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SLXN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SLXN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+1.82%
SLXN stock has given up its prior gain. Sliexion T...
Unlock content with
Pro Subscription
3 weeks ago
+1.82%
Sliexion Therapeutics shares are trading higher after the company announced it completed its preclinical study assessing SIL204.
